227. オスラー病 Osler disease Clinical trials / Disease details
臨床試験数 : 56 / 薬物数 : 72 - (DrugBank : 21) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 136
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03397004 (ClinicalTrials.gov) | September 12, 2018 | 21/11/2017 | Doxycycline for Hereditary Hemorrhagic Telangiectasia | Doxycycline Crossover Trial for Hereditary Hemorrhagic Telangiectasia | Hereditary Hemorrhagic Telangiectasia (HHT) | Drug: Doxycycline Hyclate;Drug: Placebo | Unity Health Toronto | Barrow Neurological Institute;Duke University;Feinstein Institute for Medical Research;University of Pittsburgh;Sunnybrook Health Sciences Centre | Active, not recruiting | 18 Years | N/A | All | 30 | Phase 2 | Canada |